Marshall Wace North America’s GSK GSK Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2020
Q4 | – | Sell |
-278,043
| Closed | -$13.1M | – | 1404 |
|
|
2020
Q3 | $13.1M | Buy |
+278,043
| New | +$13.1M | 0.08% | 241 |
|
|
2019
Q4 | – | Sell |
-34,362
| Closed | -$1.83M | – | 1402 |
|
|
2019
Q3 | $1.83M | Buy |
+34,362
| New | +$1.83M | 0.01% | 563 |
|
|
2019
Q2 | – | Sell |
-1,200
| Closed | -$62K | – | 1318 |
|
|
2019
Q1 | $62K | Buy |
+1,200
| New | +$62K | ﹤0.01% | 1217 |
|
|
2018
Q3 | – | Sell |
-42,862
| Closed | -$2.16M | – | 1087 |
|
|
2018
Q2 | $2.16M | Sell |
42,862
-373,700
| -90% | -$18.8M | 0.01% | 743 |
|
|
2018
Q1 | $20.3M | Sell |
416,562
-1,526,826
| -79% | -$74.6M | 0.1% | 234 |
|
|
2017
Q4 | $86.2M | Buy |
1,943,388
+381,165
| +24% | +$16.9M | 0.48% | 42 |
|
|
2017
Q3 | $80.1M | Buy |
1,562,223
+666,630
| +74% | +$34.2M | 0.51% | 23 |
|
|
2017
Q2 | $48.1M | Buy |
895,593
+534,471
| +148% | +$28.7M | 0.35% | 69 |
|
|
2017
Q1 | $19M | Buy |
+361,122
| New | +$19M | 0.15% | 181 |
|